Drugmakers scout for deals, ramp up research spending
By Manas Mishra and Patrick Wingrove (Reuters) – Drugmakers including Merck & Co, AstraZeneca Plc and AbbVie Inc said on Thursday they are open to acquisitions and reported a ramp up in research and development spending as the industry’s larger players look for new sources of future revenue. Several top drugs such as AbbVie flagship…
